Dare Bioscience, Inc. (DARE) Institutional Ownership

Ownership Summary

According to SEC filings for the period ending December 2025, Dare Bioscience, Inc. (NASDAQ:DARE) is held by 24 institutional firms.

• These investors collectively held 10.1% of the company's total shares outstanding in December 2025, down from 10.9% in September 2025.
• On a quarter-over-quarter basis, institutional holdings shifted by 31.24%, with a year-over-year a decrease of 7.69% in the count of filers.
• The latest 13F cycle for Dare Bioscience reveals that of 24 total investors, 14 funds grew their exposure, whereas 6 reduced theirs and 4 made no changes.
• The total number of shares held by institutions in Dare Bioscience increased to 941.50K as of December 2025, a net change of up by 224.12K shares quarter on quarter, and up 164.28K shares year over year.
• As of December 31, 2025, VANGUARD GROUP INC held Dare Bioscience's largest shareholding position with over 523.05K shares, representing 5.63% of total outstanding shares.
• Among the most significant buyers of Dare Bioscience during December 2025 were VANGUARD GROUP INC (128.16K), TWO SIGMA INVESTMENTS, LP (33.04K), US BANCORP \DE\ (20.92K), TWO SIGMA ADVISERS, LP (17.90K), LPL Financial LLC (14.64K).
• Leading sellers of Dare Bioscience stock in December 2025 included RENAISSANCE TECHNOLOGIES LLC (39.60K), GEODE CAPITAL MANAGEMENT, LLC (4.72K), UBS Group AG (1.71K), Cornerstone Planning Group LLC (245), BANK OF AMERICA CORP /DE/ (2).
• The top 10 institutional holders of Dare Bioscience for the quarter ending December 2025 included VANGUARD GROUP INC (523.05K), GEODE CAPITAL MANAGEMENT, LLC (118.66K), SUSQUEHANNA INTERNATIONAL GROUP, LLP (70.02K), TWO SIGMA INVESTMENTS, LP (33.04K), STATE STREET CORP (23.52K), US BANCORP \DE\ (20.92K), UBS Group AG (20.91K), RENAISSANCE TECHNOLOGIES LLC (19.30K), TWO SIGMA ADVISERS, LP (17.90K), BlackRock, Inc. (16.97K).